Revenue
2020
2021
GRI Bio, Inc. (GRI)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $100,000 |
| Research & development | $6.8M | $3.8M | $3.2M | $242,000 | $5.2M | $3.7M |
| Operating expenses | $12.0M | $8.2M | $11.4M | $2.2M | $9.3M | $4.9M |
| Operating income | −$12.0M | −$8.2M | −$11.4M | −$2.2M | −$9.3M | −$4.8M |
| Net income | −$12.0M | −$8.2M | −$13.0M | −$3.2M | −$9.3M | −$4.8M |
| Basic EPSper diluted share | -$121.80 | -$1,545.55 | -$5,018.09 | -$24.95 | -$1.42 | -$1.07 |
| Diluted EPSper diluted share | -$121.80 | -$1,545.55 | -$5,018.09 | -$24.95 | -$1.42 | -$1.07 |